SLU-PP-332 is a small-molecule agonist of the estrogen-related receptors investigated as an exercise-mimetic candidate that increases oxidative metabolism and endurance in rodents. Despite being frequently grouped with research peptides, it is not a peptide. Evidence is preclinical with no human data, and it is not approved.
Mechanism under study
A pan-agonist of the estrogen-related receptors (ERR alpha, beta, and gamma) that upregulates mitochondrial biogenesis and fatty-acid-oxidation gene programs, reproducing several transcriptional adaptations of endurance exercise in rodents.
Research-reported dosing
Preclinical only, with no human data and no approval. Rodent studies report intraperitoneal dosing on the order of 50 mg/kg; there is no established human dose. Reported context only.
Not a water-reconstituted peptide. It is a small-molecule research chemical, typically dissolved in a co-solvent such as DMSO for laboratory use rather than reconstituted with bacteriostatic water for subcutaneous injection.
Open this mix in the calculator →Dosing figures describe how this compound appears in the research literature and research-community references. They are not a recommendation for human use.
SLU-PP-332 FAQ
What is SLU-PP-332?
SLU-PP-332 is a small-molecule agonist of the estrogen-related receptors investigated as an exercise-mimetic candidate that increases oxidative metabolism and endurance in rodents. Despite being frequently grouped with research peptides, it is not a peptide. Evidence is preclinical with no human data, and it is not approved.
What is the half-life of SLU-PP-332?
Reported short systemic exposure in rodent studies; it was administered by injection in preclinical work.
What is the research-reported dosing for SLU-PP-332?
Preclinical only, with no human data and no approval. Rodent studies report intraperitoneal dosing on the order of 50 mg/kg; there is no established human dose. Reported context only.
How is SLU-PP-332 reconstituted?
Not a water-reconstituted peptide. It is a small-molecule research chemical, typically dissolved in a co-solvent such as DMSO for laboratory use rather than reconstituted with bacteriostatic water for subcutaneous injection.
Is SLU-PP-332 FDA-approved?
No — SLU-PP-332 is not FDA-approved and is sold for laboratory research use only.
References
Related peptides
5-Amino-1MQ
Small-molecule NNMT inhibitor (not a peptide)
A small-molecule inhibitor of the enzyme NNMT — not a peptide — studied mainly in cell and animal models for its effects on fat-cell metabolism and its potential to preserve NAD+.
MOTS-c
Mitochondrial-derived peptide
A mitochondrial-derived peptide studied as a metabolic regulator and exercise-mimetic in preclinical models, and of interest in aging and insulin-sensitivity research.
Tesofensine
Small-molecule triple monoamine reuptake inhibitor (not a peptide)
Tesofensine is an orally active small-molecule triple monoamine reuptake inhibitor first trialed for neurodegenerative disease and later repurposed for obesity. It is not a peptide. It remains investigational and is not FDA-approved, though it produced notable weight loss in Phase 2 obesity trials.